Brii Biosciences’ Covid drug approved

China’s National Medical Products Administration has approved a COVID-19 antibody treatment. The drug manufactured by Brii Biosciences showed an 80 percent reduction in hospitalizations and deaths, according to the Beijing-based company. More details on the effectiveness against the Omicron variant are expected in two weeks.